查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1098626

脑膜炎疫苗的市场规模、占有率、展望、机会 (2022年～2030年):各疫苗、年龄层、通路、各国

Meningitis Vaccines Market, by Vaccine, by Age Group, by Distribution Channel, and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 359 Pages | 商品交期: 2-3个工作天内

价格
简介目录

主要企业着重产品的上市及核准，推动在预测期间内的全球脑膜炎疫苗市场成长。

本报告提供全球脑膜炎疫苗的市场调查，市场定义和概要，市场成长的各种影响因素分析，法律制度，开发平台的分析，市场规模的变化、预测，各种区分、各主要国家的明细，竞争环境，主要企业简介等彙整资讯。

目录

第1章 调查目的、前提条件

第2章 市场概要

第3章 市场动态、法规、趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 市场趋势
  • 主要的展开
  • 法规情境
  • PEST分析
  • 流行病学
  • 疫苗开发週期
  • 疫苗的种类/技术及给药途径
  • 价格分析
  • 开发平台分析
  • 品牌比较製图

第4章 全球脑膜炎疫苗市场:COVID-19影响

  • 经济影响
  • COVID-19:流行病学
  • 需求与供给的分析

第5章 全球脑膜炎疫苗市场:各疫苗

  • 概要
  • 肺炎球菌结合型疫苗
  • 肺炎球菌多糖类疫苗
  • 脑膜炎疫苗
  • 其他

第6章 全球脑膜炎疫苗市场:各年龄层

  • 概要
  • 婴幼儿
  • 大人

第7章 全球脑膜炎疫苗市场:各销售管道

  • 概要
  • 政府
  • 民间

第8章 全球脑膜炎疫苗市场:各国

  • 埃及
  • 奈及利亚
  • 摩洛哥
  • 印尼
  • 孟加拉
  • 马来西亚
  • 阿拉伯联合大公国
  • 沙乌地阿拉伯
  • 巴基斯坦
  • 土耳其
  • 哈萨克
  • 约旦
  • 卡达
  • 苏丹
  • 黎巴嫩
  • 乌干达
  • 贝南共和国
  • 喀麦隆
  • 加彭
  • 象牙海岸共和国
  • 越南
  • 新加坡
  • 墨西哥
  • 阿根廷
  • 泰国
  • 菲律宾
  • 尼泊尔
  • 缅甸
  • 其他地区

第9章 竞争情形

  • GlaxoSmithKline plc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Novartis AG
  • Walvax Biotechnology Co., Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd.
  • Vacsera
  • Zhi Fei Biological
  • BIO MED
  • Chengdu Kanghua Biological Products
  • Bharat Biotech.
  • LG Chem
  • Espromed Bio
  • Panacea Biotec Limited
  • Sinovac Biotech Co., Ltd.
  • CanSinoBIO
  • Eubiologics Co., Ltd.

第10章 Section

简介目录
Product Code: CMI5042

Meningitis is an inflammation of the tissue layers that surround the brain and spinal cord (meninges) as well as the fluid-filled area between the meninges (subarachnoid space). Meningitis can be caused by bacteria, viruses, fungus, or non-infectious illnesses. Meningitis symptoms include headache, fever, and a stiff neck that makes lowering the chin to the chest difficult or impossible, though infants may not have a stiff neck and symptoms may differ in the elderly and individuals who use immune-suppressing medicines. Vaccination is a safe option to develop immunity against meningitis. Immunization of individuals most at risk of being infected helps to protect the individuals from meningitis, prevents its spread within communities, and eventually benefits the entire population. However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.

Market Dynamics

Key companies in the market are focusing on product launches and approvals for meningitis vaccines which is expected to boost the global meningitis vaccines market growth over the forecast period. For instance, in June 2021, CanSinoBIO, an innovative biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has a trade name: Menphecia. Menphecia delivers protection against infection of Group A and C Neisseria meningitides.

Moreover, in May 2019, the Ministry of Health of Ireland had approved the menACWY vaccine to be administered to thousands of children & adults in Ireland due to rising cases of meningitis that were reported in 2018.

Key features of the study:

  • This report provides in-depth analysis of the global meningitis vaccines market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Novartis AG, Walvax Biotechnology Co., Ltd., Incepta Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Vacsera, Zhi Fei Biological, BIO MED, Chengdu Kanghua Biological Products, Bharat Biotech., LG Chem, Espromed Bio, Panacea Biotec Limited, Sinovac Biotech Co., Ltd., CanSinoBIO, and Eubiologics Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningitis vaccines market

Detailed Segmentation:

  • Global Meningitis Vaccines Market, By Vaccine:
    • Pneumococcal Conjugate Vaccine
    • Pneumococcal Polysaccharide Vaccine
    • Meningococcal Vaccine
    • Others
  • Global Meningitis Vaccines Market, By Age Group:
    • Infants
    • Adults
  • Global Meningitis Vaccines Market, By Distribution Channel:
    • Government
    • Private
  • Global Meningitis Vaccines Market, By Country:
    • Egypt
    • Nigeria
    • Morocco
    • Indonesia
    • Bangladesh
    • Malaysia
    • United Arab Emirates
    • Saudi Arabia
    • Pakistan
    • Turkey
    • Kazakhstan
    • Jordan
    • Qatar
    • Sudan
    • Lebanon
    • Uganda
    • Benin
    • Cameroon
    • Gabon
    • Cote d'Ivoire
    • Vietnam
    • Singapore
    • Mexico
    • Argentina
    • Thailand
    • Philippines
    • Nepal
    • Myanmar
    • Rest of the World
  • Company Profiles
    • GlaxoSmithKline plc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Novartis AG
    • Walvax Biotechnology Co., Ltd.
    • Incepta Pharmaceuticals Ltd.
    • Serum Institute of India Pvt. Ltd.
    • Vacsera
    • Zhi Fei Biological
    • BIO MED
    • Chengdu Kanghua Biological Products
    • Bharat Biotech.
    • LG Chem
    • Espromed Bio
    • Panacea Biotec Limited
    • Sinovac Biotech Co., Ltd.
    • CanSinoBIO
    • Eubiologics Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine
    • Market Snapshot, By Age Group
    • Market Snapshots, By Distribution Channel
    • Market Snapshot, By Country
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Epidemiology
  • Vaccine Development Cycle
  • Vaccine Types/Technology and Route of Administration
  • Pricing Analysis
  • Pipeline Analysis
  • Brand Comparison Mapping

4. Global Meningitis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Demand and Supply Analysis

5. Global Meningitis Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pneumococcal Conjugate Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Pneumococcal Polysaccharide Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Meningococcal Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Meningitis Vaccines Market, By Age Group, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Infants
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Adults
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Meningitis Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Government
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Private
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Meningitis Vaccines Market, By Country, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Country, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Countries, 2018-2030
    • Country Trends
  • Egypt
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Nigeria
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Morocco
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Indonesia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Bangladesh
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Malaysia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • United Arab Emirates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Saudi Arabia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Pakistan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Turkey
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Kazakhstan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Jordan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Qatar
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Sudan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Lebanon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Uganda
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Benin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Cameroon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Gabon
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Cote d'Ivoire
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Vietnam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Singapore
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Mexico
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Argentina
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Thailand
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Philippines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Nepal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Myanmar
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Rest of the World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)

9. Competitive Landscape

  • GlaxoSmithKline plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Walvax Biotechnology Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Incepta Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vacsera
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zhi Fei Biological
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BIO MED
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chengdu Kanghua Biological Products
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bharat Biotech.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LG Chem
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Espromed Bio
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Panacea Biotec Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sinovac Biotech Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CanSinoBIO
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eubiologics Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us